Neuromyelitis optica is complex, and the best care for it is constantly evolving. Each year, Mayo Clinic doctors diagnose and treat more than 3,500 adults and children with neuromyelitis optica (NMO) and other central nervous system disorders including multiple sclerosis, optic neuritis, transverse myelitis and acute disseminated encephalomyelitis.
Although NMO is relatively uncommon, Mayo Clinic doctors treat more than 150 people with NMO annually, either on-site or through coordination with individuals' doctors at home.
We meet all your needs under one roof. Mayo Clinic's multidisciplinary approach ensures that you have a team of specialists collaborating on all aspects of your care.
Doctors trained in brain and nervous system conditions (neurologists), eye and nervous system conditions (neuro-ophthalmologists), physical medicine and rehabilitation (physiatrists), pain medicine, laboratory medicine, and other areas work together to evaluate and treat people with NMO and related disorders.
- Pediatric center. The National Multiple Sclerosis Society has recognized the Pediatric Multiple Sclerosis Center at Mayo Clinic in Minnesota as a Pediatric MS Center of Excellence. The multidisciplinary center focuses on the evaluation and treatment of children with multiple sclerosis, NMO and other central nervous system disorders.
Our mission to find and share better medical expertise means close contact with people working to discover affected people as early as possible, enhancing understanding of the disease and improving treatment for neuromyelitis optica.
Neurologists and scientists at Mayo Clinic discovered an autoantibody, NMO-IgG, that is a specific marker of NMO. This antibody may help doctors diagnose neuromyelitis optica and can help identify the disorder from multiple sclerosis.
Our commitment to expand knowledge for all NMO patients drives current research, as well as our clinical trials of new therapies.
Mayo Clinic in Rochester, Minn., is ranked among the Best Hospitals for neurology and neurosurgery and for rehabilitation, and is ranked high performing for ophthalmology by U.S. News & World Report.
Sept. 19, 2015
- Pereira W, et al. Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: A review. Journal of the Neurological Sciences. 2015;355:7.
- NINDS neuromyelitis optica information page. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/neuromyelitis_optica/neuromyelitis_optica.htm. Accessed Sept. 3, 2015.
- Wingerchuk DM, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85:177.
- Symptoms and diagnosis of NMO. National Multiple Sclerosis Society. http://www.nationalmssociety.org/What-is-MS/Related-Conditions/Neuromyelitis-Optica-(NMO)/Symptoms-and-Diagnosis. Accessed Sept. 3, 2015.
- Riggin EA. Enterprise Performance Management system. Mayo Clinic, Rochester, Minn. July 22, 2015.
- Network of pediatric MS centers. National Multiple Sclerosis Society. http://www.nationalmssociety.org/What-is-MS/Who-Gets-MS/Pediatric-MS/Care-for-Pediatric-MS-(Centers-of-Excellence). Accessed Sept. 3, 2015.
- Glisson CC. Neuromyelitis optica (NMO) and NMO spectrum disorders. http://www.uptodate.com/home. Accessed Sept. 3, 2015.
- Matiello M, et al. Neuromyelitis optica. Current Opinion in Neurology. 2007;20:255.
- Riggin EA. Enterprise Performance Management system. Mayo Clinic, Rochester, Minn. Sept. 3, 2015.
- Wingerchuk DM, et al. The spectrum of neuromyelitis optica. Lancet Neurology. 2007;6:805.